Search results for Anti-Insulin Antibody

Anti-Insulin Antibody, Covalab, Ref 00123710

Anti-Insulin antibody, Abcam, AB210560

Anti-Insulin antibody, Abcam, AB53591

Anti-Insulin antibody, Abcam, AB63820

Anti-Insulin antibody [E2E3], Abcam, AB9569

Anti-Insulin antibody [EPR17359], Abcam, AB181547

Product Specifications Anti-Insulin antibody [EPR17359] (ab181547) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in ICC/IF, IHC-FoFr, IHC-P, WB, mIHC in human, mouse, rat samples. Anti-Insulin antibody [EPR17359] (ab181547) specifically detects Insulin (UniProt ID: P01308; Molecular weight: 3kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Insulin antibody [EPR17359] (ab181547) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Insulin antibody [EPR17359] (ab181547) has been cited over 98 times in peer reviewed journals and is trusted by the scientific community. Anti-Insulin antibody [EPR17359] (ab181547) has 11 independent reviews from customers. Related Products Antibody clone EPR17359 is also available pre-conjugated to a variety of labels for your convenience - PE ( ab213192 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Insulin antibody [EPR3074], Abcam, AB133281

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Insulin antibody [RM1019], Abcam, AB282459

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

Biotin Anti-Insulin antibody, Abcam, AB53592

PE Anti-Insulin antibody [EPR17359], Abcam, AB213192

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .